BRPI0908024A2 - uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer - Google Patents

uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer

Info

Publication number
BRPI0908024A2
BRPI0908024A2 BRPI0908024A BRPI0908024A BRPI0908024A2 BR PI0908024 A2 BRPI0908024 A2 BR PI0908024A2 BR PI0908024 A BRPI0908024 A BR PI0908024A BR PI0908024 A BRPI0908024 A BR PI0908024A BR PI0908024 A2 BRPI0908024 A2 BR PI0908024A2
Authority
BR
Brazil
Prior art keywords
adenosylmethionine
sod
sam
medicaments
alzheimer
Prior art date
Application number
BRPI0908024A
Other languages
English (en)
Inventor
Fuso Andrea
Rossini Mauro
Damiani Rosellina
Scarpa Sigfrido
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of BRPI0908024A2 publication Critical patent/BRPI0908024A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0908024A 2008-02-29 2009-02-25 uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer BRPI0908024A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08425123A EP2095828A1 (en) 2008-02-29 2008-02-29 Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease
PCT/EP2009/001323 WO2009106302A1 (en) 2008-02-29 2009-02-25 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
BRPI0908024A2 true BRPI0908024A2 (pt) 2018-11-06

Family

ID=39529658

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908024A BRPI0908024A2 (pt) 2008-02-29 2009-02-25 uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer

Country Status (25)

Country Link
US (1) US8778337B2 (pt)
EP (2) EP2095828A1 (pt)
JP (1) JP5362747B2 (pt)
KR (1) KR101297763B1 (pt)
CN (2) CN101965197A (pt)
AU (1) AU2009218723B2 (pt)
BR (1) BRPI0908024A2 (pt)
CA (1) CA2716893C (pt)
CY (1) CY1116782T1 (pt)
DK (1) DK2249868T3 (pt)
ES (1) ES2550461T3 (pt)
GE (1) GEP20125638B (pt)
HR (1) HRP20151241T1 (pt)
HU (1) HUE028183T2 (pt)
IL (1) IL207807A (pt)
MX (1) MX2010009384A (pt)
NZ (1) NZ587608A (pt)
PL (1) PL2249868T3 (pt)
PT (1) PT2249868E (pt)
RS (1) RS54442B1 (pt)
RU (1) RU2472513C2 (pt)
SI (1) SI2249868T1 (pt)
UA (1) UA97440C2 (pt)
WO (1) WO2009106302A1 (pt)
ZA (1) ZA201006085B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150064423A (ko) * 2013-12-03 2015-06-11 경상대학교산학협력단 오스모틴을 유효성분으로 함유하는 인지기능 개선용 조성물
KR101689681B1 (ko) * 2016-06-07 2016-12-26 경상대학교산학협력단 오스모틴을 유효성분으로 함유하는 인지기능 개선용 조성물
WO2023055198A1 (ko) 2021-09-30 2023-04-06 한국한의학연구원 반하, 대추, 감초, 인삼, 건강, 황금 및 황련 혼합 추출물을 유효성분으로 포함하는, 알츠하이머 치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519058A (en) * 1989-03-17 1996-05-21 Cedars-Sinai Medical Center Method for treatment with dimercaptosuccinic acid (DMSA) of hypertension, diabetic neuphropathy and atherosclerosis
CN1099224A (zh) * 1993-08-23 1995-03-01 庭野七郎 人参叶加工的食品及其制造方法
US6096778A (en) * 1997-10-07 2000-08-01 Cephalon, Inc. α-ketoamide multicatalytic protease inhibitors
US6797289B2 (en) * 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20020025926A1 (en) * 2000-08-30 2002-02-28 Hebert Rolland F. Enantiomers of S-adenosyl-l-methionine
IT1317920B1 (it) 2000-10-20 2003-07-15 Univ Roma S-adenosilmetionina e suoi derivati per il trattamento e laprevenzione della malattia di alzheimer.
US6759395B2 (en) * 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
FR2822381B1 (fr) * 2001-03-20 2004-10-22 Bio Obtention Sc Extrait de cucumis melo enrobe et/ou microencapsule dans un agent liposoluble a base de matiere grasse
ITMI20012462A1 (it) * 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
AU2003298514A1 (en) * 2002-05-17 2004-05-04 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
WO2005041996A1 (en) * 2003-10-03 2005-05-12 GREEN MEADOWS RESEARCH, LLC A & L Goodbody Lotus and methyl donors
DK1731596T5 (da) * 2005-06-09 2013-09-23 Gnosis Spa Tørrede, frysetørrede og/eller mikroindkapslede celler af Saccharomyces cerevisiae med et højt indhold af (S)-(+)-S-adenosyl-L-methionin

Also Published As

Publication number Publication date
KR101297763B1 (ko) 2013-08-20
WO2009106302A1 (en) 2009-09-03
PT2249868E (pt) 2015-11-03
DK2249868T3 (en) 2015-11-23
US8778337B2 (en) 2014-07-15
EP2249868A1 (en) 2010-11-17
NZ587608A (en) 2012-07-27
CN101965197A (zh) 2011-02-02
HUE028183T2 (en) 2016-12-28
AU2009218723A1 (en) 2009-09-03
AU2009218723B2 (en) 2014-01-30
CN104189895B (zh) 2016-08-31
EP2095828A1 (en) 2009-09-02
HRP20151241T1 (hr) 2015-12-18
US20110020301A1 (en) 2011-01-27
CA2716893C (en) 2014-05-20
JP2011513257A (ja) 2011-04-28
IL207807A (en) 2015-08-31
IL207807A0 (en) 2010-12-30
RU2010135467A (ru) 2012-04-10
CA2716893A1 (en) 2009-09-03
MX2010009384A (es) 2010-12-21
KR20100126326A (ko) 2010-12-01
RS54442B1 (en) 2016-06-30
UA97440C2 (en) 2012-02-10
ZA201006085B (en) 2011-10-26
PL2249868T3 (pl) 2016-03-31
EP2249868B1 (en) 2015-09-02
ES2550461T3 (es) 2015-11-10
GEP20125638B (en) 2012-09-10
SI2249868T1 (sl) 2015-12-31
CN104189895A (zh) 2014-12-10
CY1116782T1 (el) 2017-03-15
JP5362747B2 (ja) 2013-12-11
RU2472513C2 (ru) 2013-01-20

Similar Documents

Publication Publication Date Title
CY2017013I2 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
CL2007003635A1 (es) Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer.
BRPI0911874A2 (pt) composições combinadas para o tratamento da doença de alzheimer e doenças relacionadas com zonisamida e acamprosato
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
BRPI0906576A2 (pt) Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
BRPI1014854A2 (pt) "conjugados polímero-agente, partículas, composições, e métodos de uso relacionados"
HK1124552A1 (en) Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
IL204741A (en) Ceramide History for the Treatment of Multiple Cyst Diseases and Pharmaceuticals Containing These History
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
IL212568A (en) Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals
BRPI0819501A2 (pt) "dispositivo para fototerapia, método cosmético para bronzeamento, uso do dispositivo, kit, uso de curcumia, curcuminoides, pró-drogas ou metabólitos dos mesmos e composição farmacêutica"
BRPI0720689A2 (pt) Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer
BRPI0910737A2 (pt) composto, pró-droga, agente farmacêutico, método para profilaxia ou tratamento de doenças do trato urinário inferior em um mamífero, e, uso de um composto ou uma pró-droga do mesmo.
IL196606A (en) Use of Eskin for the preparation of medical preparations and medical preparations containing Eskin for the treatment of diseases
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
CL2008000318A1 (es) Compuestos derivados de n-(2,3,4,4a,5,6-hexahidro-1h-pirazino(1,2-a)quinolina-8-carbonil)bencenosulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar el cancer de vejiga, cerebro, m
DE602006005246D1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
BRPI0818267A2 (pt) Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BRPI0817483A2 (pt) uso de n-fenilamidas de ácido 2-sulfonilaminobenzoico substituídas por sulfonila no tratamento da dor
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL